Literature DB >> 6209786

Depressed NK cell activity of peripheral blood mononuclear cells in untreated hodgkin's disease: enhancing effect of interferon in vitro.

S Levy, J L Tempe, A Aleksijevic, C Giron, F Oberling, S Mayer, J M Lang.   

Abstract

Natural killer (NK) cell activity of unseparated peripheral blood mononuclear cells from 30 untreated patients with Hodgkin's disease and 22 age- and sex-matched normal controls was evaluated using the classical K 562 cells as targets. A significant defect was demonstrated in the patients with stage I-II and seemed to be more profound in patients with advanced disease (stage III-IV) and in those with B symptoms. The differences between subgroups of patients, however, were not statistically significant, mostly because of the wide dispersion of individual data. Pre-incubation of effector cells with alpha A leucocyte recombinant interferon led to a clear increase in NK cell activity in 4 of 6 patients tested, showing that depressed NK activity in Hodgkin's disease is still susceptible to the enhancing effect of interferon, at least in some patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6209786     DOI: 10.1111/j.1600-0609.1984.tb00712.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  4 in total

1.  Natural killing activity in patients with spontaneous regression of malignant lymphoma.

Authors:  K Ono; M Kikuchi; N Funai; M Matsuzaki; Y Shimamoto
Journal:  J Clin Immunol       Date:  1996-11       Impact factor: 8.317

2.  Normal natural killer cell activity in Hodgkin's disease patients in remission.

Authors:  D Douer; N Shaked; B Ramot
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

3.  Stage-related decrease in natural killer cell activity in untreated patients with mycosis fungoides.

Authors:  S Levy; J L Tempé; P Caussade; A Aleksijevic; E Grosshans; S Mayer; J M Lang
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

4.  Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.

Authors:  N Rajaram; R J Tatake; S H Advani; S G Gangal
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.